APSR2026-309

Yes
Late-Breaking
Submitted
Oral Presentation
AO03-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1217844-46903-APSR2026-309_439863.pptx
Format: PPTX Only
 
Format: PDF Only
07. COPD
11

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Shuo Wang * The Chinese University of Hong Kong Department of Paediatrics Hong Kong Hong Kong
Joan Marie Javillo Baguio - The Chinese University of Hong Kong Department of Paediatrics Hong Kong Hong Kong
Tony Chun Hei Lei - The Chinese University of Hong Kong Department of Paediatrics Hong Kong Hong Kong
Isabel Zhao - The Chinese University of Hong Kong Department of Paediatrics Hong Kong Hong Kong
Yang Wu - The Hong Kong University of Science and Technology Division of Life Science Hong Kong Hong Kong
Pui Yee Wong - The Hong Kong University of Science and Technology Division of Life Science Hong Kong Hong Kong
Zeqi Sun - The Chinese University of Hong Kong Department of Chemical Pathology Hong Kong Hong Kong
Zhen Liu - The Chinese University of Hong Kong Division of Life Science Hong Kong Hong Kong
Chi Chiu Wang - The Chinese University of Hong Kong Department of Obstetrics and Gynaecology Hong Kong Hong Kong
Fanny Wai San Ko - The Chinese University of Hong Kong Department of Medicine and Therapeutics Hong Kong Hong Kong
Renee Wan Yi Chan - The Chinese University of Hong Kong Department of Paediatrics Hong Kong Hong Kong
 
 
 
 
Presenting Author Details
Shuo
Wang
shuo.wang@link.cuhk.edu.hk
+85254978532
Under 30
 
Original Research
Restoration of remodeled chronic obstructive pulmonary disease airway epithelium by human umbilical cord blood small extracellular vesicles
Maximum 25 words
Abstract Content
Chronic obstructive pulmonary disease (COPD) contributes significant death and morbidity worldwide. Current treatments inadequately address the underlying structural and functional defects of diseased airways, highlighting an urgent need for regenerative therapeutics. Human umbilical cord blood small extracellular vesicles (hUCB-sEVs), enriched in regenerative bioactive cargoes from multiple progenitor cell types, have emerged as a promising candidate treatment. We constructed patient derived COPD airway organoids that recapitulate disease severity gradients and enable high-throughput screening. We conducted a comprehensive evaluation of the therapeutic efficacy, mechanism, short-term therapeutic and long-term regenerative potential of hUCB-sEVs in COPD treatment.
COPD organoid was constructed from patients’ nasopharyngeal swab with basal cell-to-air-liquid interface-to-airway organoid differentiation trajectory. hUCB-sEVs were extracted by size exclusion chromatography. Labelled-sEVs were used to determine uptake dynamics, and sorting flow cytometric sorting stratified cells by intensity which reflects sEV-receptibility. Single-cell RNA sequencing of sorted populations delineated hUCB-sEV treatment mechanisms. Peripheral blood-derived (PB)-sEVs from age-matched non-pregnant females severed as controls. Therapeutic efficacy was evaluated by qPCR and immunostaining to capture functional readouts.
COPD organoids could intake hUCB-sEV within 24 hours. At 1:20,000 cell-to-sEV ratio, the hUCB-sEVs demonstrated the greatest therapeutic response, significantly ameliorating Collagen, Notch and Semaphorin-4 pathway gene by decreasing aberrant intercellular communication. Cells with high hUCB-sEV-receptibility resulted in better restoration. Compared to PB-sEVs, hUCB-sEVs elicited superior therapeutic response. hUCB-sEVs restored basal cell homeostasis, reduced goblet cell hyperplasia, decreased mucus hyperproduction, and downregulated collagen and EMT marker expression in a dose-dependent manner. Long-term treatment enhanced cell proliferation, improved barrier and ciliary function and attenuated pathological airway remodeling through targeted modulation of COPD basal cells.
This study illustrated the robust therapeutic potential of hUCB-sEVs in COPD, with no obvious of off-target effects, providing a solid preclinical foundation for the advancement of hUCB-sEV toward clinical therapy from-bench-to-bedside.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Chronic obstructive pulmonary disease, regenerative therapy, human umbilical cord blood small extracellular vesicles
maximum 3 keywords and no abbreviations, separated by commas
No
293